Consistent with the results of our previous study [11], the expression of SOX2, a JICD1 downstream gene, and OLIG2, a marker of GBM, was increased by JICD1 overexpression in 528NS tumors (Figure 4G and Supplementary Figure S4C). This evidence concerns the gene OLIG2 and glioblastoma.